# Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

> **NCT00005790** · NA · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** biopsy
- **PROCEDURE:** magnetic resonance imaging
- **RADIATION:** gadopentetate dimeglumine

## Key facts

- **NCT ID:** NCT00005790
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1996-04
- **Primary completion:** 1999-05
- **Final completion:** 1999-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to accrue subjects.
- **Last updated:** 2012-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005790, "Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00005790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*